期刊文献+

Non-HDL-C对心梗风险与冠脉病变程度及冠心病预测中价值的研究进展 被引量:3

下载PDF
导出
摘要 非高密度脂蛋白胆固醇(Non-HDL-C)是总胆固醇(TC)除去高密度脂蛋白胆固醇外,包含了低密度脂蛋白胆固醇(LDL-C)、极低密度脂蛋白胆固醇(VLDL-C)、中间密度脂蛋白胆固醇(IDL-C)、乳糜微粒(CM)以及脂蛋白(a)等各种脂蛋白胆固醇的总和。其与LDL-C不同,Non-HDLC能够准确地表现出造成动脉粥样硬化脂蛋白颗粒的胆固醇水平,在目前,通过对不同人群的多种研究,均将重点指向了Non—HDL—C在冠心病中的作用及价值。
出处 《现代中西医结合杂志》 CAS 2016年第4期453-456,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献21

  • 1Kitamura A, Noda H, Nakamura M, et al. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese:the Circulatory Risk in Communities Study ( CIRCS) [ J ]. J Atheroscler Thromb,2011,18(6) :454 — 463.
  • 2许海燕,乔树宾,张家芬,徐波,顼志敏,杨跃进,董秋婷.非高密度脂蛋白胆固醇对冠状动脉病变的影响[J].中国动脉硬化杂志,2010,18(5):409-411. 被引量:8
  • 3Sniderman AD,Islam S, Yusuf S,et al. Discordance analysis of apo-lipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study[ J]. Atherosclerosis ,2012 ,225 (2) :444 -449.
  • 4Ke D , Chen Q, Wu Q , et al. Analysis of the correlation between non-high density lipoprotein cholesterol and coronary heart disease in elderly Chinese[ J]. Intern Med,2011,50(12) :1279 - 1285.
  • 5Mora S,Glynn RJ,Boekholdt SM ,et al. On-treatment non-high-den-sity lipoprotein cholesterol,apolipoprotein B,triglycerides,and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy : JUPITER (justification for the use of statins in prevention :an intervention trial evaluating rosuvastatin) [ J ] . J AmColl Cardiol,2012,59(17) :1521 - 1528.
  • 6Robinson JG, Wang S,Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials [ J ]. Am J Cardiol, 2012,110(10) :1468 - 1476.
  • 7Mahajan N,Ference BA,Arora N,et al. Role of non-high-density li~ poproteincholesterol in predicting cerebrovascular events in patients following myocardial infarction[ J]. Am J Cardiol,2012 ,109 ( 12 ); 1694 -1699.
  • 8Boekholdt SM,Arsenault BJ,Mora S,et al. Association of LDL cholesterol ,non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis[J]. JAMA,2012,307(12) :1302 -1309.
  • 9Goldstein LB , Bushnell CD , Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke,2011 ,42(2) :517 -584.
  • 10Tanabe N, Iso H, Okada K, et al. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular e-vents-the JALS - ECC - [J]. Circ Jf2010,74(7) : 1346 -1356.

二级参考文献30

  • 1李莹,陈志红,周北凡,李义和,武阳丰,刘小清,赵连成,麦劲壮,杨军,石美玲,田秀珍,关渭全,于学海,陈磊.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7):643-647. 被引量:329
  • 2徐凯,韩雅玲,荆全民,王守力,马颖艳,栾波,王祖禄,王冬梅.他汀类药物减少冠心病患者支架术后再狭窄的影响因素及意义[J].中国动脉硬化杂志,2005,13(5):607-609. 被引量:14
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4江柳月,刘建平,陶如琦,金叔宣,杜勇平,宋玮,王彬尧,何奔.老年冠心病患者血浆非高密度脂蛋白胆固醇水平的差异[J].中国动脉硬化杂志,2007,15(2):117-119. 被引量:3
  • 5Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel IIl guidelines [ J]. Circulation, 2004, 110 (2): 227-239.
  • 6Miller M, Ginsberg HN, Schaefer EJ. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease [J]. Am J Cardiol, 2008, 101 (7) : 1 003-008.
  • 7Robinson JG, Wang S, Smith B J, et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk [ J ]. J Am Coll Cardiol, 2009, 53 (4) : 316-322.
  • 8Ballantyne CM, Raichlen JS, Cain VA. Statin therapy alters the relationship between apolipaprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial [J]. J Am Coll Cardiol, 2008, 52 (8) : 626-632.
  • 9Orakzai SH, Nasir K, Blaha M ,et al. non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals [ J]. Atherosclerosis, 2009, 202 ( 1 ) : 289-295.
  • 10Schulze MB,Shai I,Manson JE,et al.Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.Diabetologia,2004,47:2129-2136.

共引文献40

同被引文献21

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部